Clinical Trials on Prostate Cancers in New Zealand
Total 7934 results
-
Noxopharm LimitedCompletedCancerNew Zealand, Georgia, Australia
-
Telix Pharmaceuticals (Innovations) Pty LtdRecruitingMetastatic Prostate CancerAustralia, New Zealand
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedRecurrent Prostate Carcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
OHSU Knight Cancer InstituteBristol-Myers Squibb; Oregon Health and Science UniversityCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)RecruitingStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8United States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage III Prostate Cancer | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Carcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Roswell Park Cancer InstituteMerck Sharp & Dohme LLCTerminatedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedNeuroendocrine Prostate Cancer | Small Cell Prostate Cancer | Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine MarkersUnited States
-
Memorial Sloan Kettering Cancer CenterProgenics Pharmaceuticals, Inc.Active, not recruitingProstate Cancer | Metastatic Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic | Prostate NeoplasmUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Novartis PharmaceuticalsTerminatedProstate Cancer | Castrate Resistant Prostate Cancer | Chemotherapy Naive Prostate CancerUnited States
-
National Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Roswell Park Cancer InstituteAIM ImmunoTech Inc.SuspendedProstate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer... and other conditionsUnited States
-
Astellas Pharma IncAstellas Pharma US, Inc.CompletedProstate Cancer | Cancer of the Prostate | Prostatic Cancer | Cancer of ProstateNetherlands, United States, United Kingdom
-
Beth Israel Medical CenterRiverside Research InstituteCompletedClinical Stage T2b or Less of Prostate Cancer | Prostate Brachytherapy | Transrectal Prostate Ultrasound Treatment PlanningUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingProstate Cancer | Castration-resistant Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic | Prostate NeoplasmUnited States
-
Icahn School of Medicine at Mount SinaiPhilips HealthcareUnknownProstate Disease | Elevated Prostate Specific Antigen | Family History of Prostate Cancer | Positive Digital Rectal ExamUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration Resistant Prostate Cancer | Prostate Carcinoma Metastatic to the BoneUnited States
-
ImaginAb, Inc.CompletedMetastatic Prostate CancerUnited States
-
Columbia UniversityActive, not recruitingMetastatic Prostate CancerUnited States
-
Steba Biotech S.A.WithdrawnLocalized Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedProstate Cancer | Localized Prostate CancerUnited States
-
Cytogen CorporationUnknownMetastatic Prostate CancerUnited States
-
Accuray IncorporatedCompletedProstatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic CancerUnited States
-
Bellicum PharmaceuticalsSuspendedMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, Australia; Novartis Pharmaceuticals and other collaboratorsCompletedProstate CancerAustralia, New Zealand
-
SanofiCompletedProstate Cancer MetastaticIndia
-
Memorial Sloan Kettering Cancer CenterCompletedCancer | Prostate | Hormonal CyclingUnited States
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI)RecruitingStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States
-
Roswell Park Cancer InstituteActive Biotech ABCompletedMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage I Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
ORIC PharmaceuticalsRecruitingMetastatic Prostate Cancer | Neuroendocrine Prostate CancerUnited States
-
Roswell Park Cancer InstituteDendreonCompletedMetastatic Malignant Neoplasm in the Bone | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Stage IV Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
St Vincent's Hospital, SydneyRecruitingMetastatic Prostate CancerAustralia
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkRecruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
Tulane UniversityBlue Earth DiagnosticsCompletedMetastatic Castration-resistant Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterProgenics Pharmaceuticals, Inc.CompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Peter MacCallum Cancer Centre, AustraliaUnknownProstate CancerAustralia, New Zealand
-
Exosome Diagnostics, Inc.Yale UniversitySuspendedMetastatic Castrate Resistant Prostate CancerUnited States
-
Jodi Layton, MDEMD SeronoTerminatedMetastatic Castration-resistant Prostate CancerUnited States